Skip to main content

Articles

Page 60 of 71

  1. To examine the potential improvement in treatment planning for patients with skull base meningioma using IMRT compared to carbon ion or proton beams with and without a gantry.

    Authors: Katsura Kosaki, Swantje Ecker, Daniel Habermehl, Stefan Rieken, Oliver Jäkel, Klaus Herfarth, Jürgen Debus and Stephanie E Combs
    Citation: Radiation Oncology 2012 7:44
  2. The natural history of non-metastatic castrate refractory prostate cancer is unknown and treatment options are limited. We present a retrospective review of 13 patients with locally advanced or high risk prost...

    Authors: Abigail C Pascoe and Santhanam Sundar
    Citation: Radiation Oncology 2012 7:43
  3. Our research group has previously published a dosimetric planning study that demonstrated that a 60 Gy/10 fractions intralesional boost with whole-brain radiotherapy (WBRT) to 30 Gy/10 fractions was biological...

    Authors: George Rodrigues, Slav Yartsev, Keng Yeow Tay, Gregory R Pond, Frank Lagerwaard and Glenn Bauman
    Citation: Radiation Oncology 2012 7:42
  4. Particle irradiation was established at the University of Heidelberg 2 years ago. To date, more than 400 patients have been treated including patients with primary brain tumors. In malignant glioma (WHO IV) pa...

    Authors: Stefan Rieken, Daniel Habermehl, Thomas Haberer, Oliver Jaekel, Jürgen Debus and Stephanie E Combs
    Citation: Radiation Oncology 2012 7:41
  5. Total skin electron irradiation (TSEI) is a special radiotherapy technique which has generally been used for treating adult patients with mycosis fungoides. Recently, two infants presented with leukemia cutis ...

    Authors: Qinan Bao, Brian A Hrycushko, Joseph P Dugas, Frederick H Hager and Timothy D Solberg
    Citation: Radiation Oncology 2012 7:40
  6. Histone modifications and DNA methylation are two major factors in epigenetic phenomenon. Unlike the histone deacetylase inhibitors, which are known to exert radiosensitizing effects, there have only been a fe...

    Authors: HakJae Kim, JinHo Kim, EuiKyu Chie, Park DaYoung, InAh Kim and IlHan Kim
    Citation: Radiation Oncology 2012 7:39
  7. We aimed to assess whether gross tumor volume (GTV) determined by fusion of contrast-enhanced computerized tomography (CT) and 18F-fluoro-deoxy-D-glucose positron emission tomography-CT (FDG-PET-CT) based radi...

    Authors: Cem Parlak, Erkan Topkan, Cem Onal, Mehmet Reyhan and Ugur Selek
    Citation: Radiation Oncology 2012 7:37
  8. Complete metastasectomy provides a real chance for long-term survival in patients with oligometastatic colorectal cancer (CRC). For inoperable patients, we evaluated in this study intensity-modulated and image...

    Authors: Benedikt Engels, Thierry Gevaert, Hendrik Everaert, Peter De Coninck, Alexandra Sermeus, Nicolas Christian, Guy Storme, Dirk Verellen and Mark De Ridder
    Citation: Radiation Oncology 2012 7:34
  9. While conventionally fractionated radiation therapy alone is an acceptable option for poor prognostic patients with unresectable stage III NSCLC, we hypothesized that accelerated hypofractionated radiotherapy ...

    Authors: Arya Amini, Steven H Lin, Caimiao Wei, Pamela Allen, James D Cox and Ritsuko Komaki
    Citation: Radiation Oncology 2012 7:33
  10. Consistent delineation of patient anatomy becomes increasingly important with the growing use of highly conformal and adaptive radiotherapy techniques. This study investigates the magnitude and 3D localization...

    Authors: Charlotte L Brouwer, Roel JHM Steenbakkers, Edwin van den Heuvel, Joop C Duppen, Arash Navran, Henk P Bijl, Olga Chouvalova, Fred R Burlage, Harm Meertens, Johannes A Langendijk and Aart A van 't Veld
    Citation: Radiation Oncology 2012 7:32
  11. Biochemical control from series in which radical prostatectomy is performed for patients with unfavorable prostate cancer and/or low dose external beam radiation therapy are given remains suboptimal.

    Authors: Pedro J Prada, Lucia Mendez, José Fernández, Herminio González, Isabel Jiménez and Elisabeth Arrojo
    Citation: Radiation Oncology 2012 7:31
  12. Iodine-125 brachytherapy has been applied to brain tumours since 1979. Even though the physical and biological characteristics make these implants particularly attractive for minimal invasive treatment, the pl...

    Authors: Silke B Schwarz, Niklas Thon, Katharina Nikolajek, Maximilian Niyazi, Joerg-Christian Tonn, Claus Belka and Friedrich-Wilhelm Kreth
    Citation: Radiation Oncology 2012 7:30
  13. We retrospectively reviewed magnetic resonance (MR) images of 96 patients with diagnosis of rectal cancer to evaluate tumour stage (T stage), involvement of mesorectal fascia (MRF), and nodal metastasis (N sta...

    Authors: Sabina Giusti, Piero Buccianti, Maura Castagna, Elena Fruzzetti, Silvia Fattori, Elisa Castelluccio, Davide Caramella and Carlo Bartolozzi
    Citation: Radiation Oncology 2012 7:29
  14. To evaluate efficacy and secondary resectability in patients with locally advanced pancreatic cancer (LAPC) treated with neoadjuvant chemoradiotherapy (CRT).

    Authors: Daniel Habermehl, Kerstin Kessel, Thomas Welzel, Holger Hof, Amir Abdollahi, Frank Bergmann, Stefan Rieken, Jürgen Weitz, Jens Werner, Peter Schirmacher, Markus W Büchler, Jürgen Debus and Stephanie E Combs
    Citation: Radiation Oncology 2012 7:28
  15. We developed a new method for immobilization of the fix lower extremities by using a thermoplastic mask, a carbon fiber base plate, a customized headrest, and an adjustable angle holder. The lower extremities ...

    Authors: Xuhai Zheng, Tangzhi Dai, Xiaochuan Shu, Yuanxue Pu, Gang Feng, Xuesong Li, Dongbiao Liao and Xiaobo Du
    Citation: Radiation Oncology 2012 7:27
  16. Vosaroxin is a first in class naphthyridine analog structurally related to quinolone antibacterials, that intercalates DNA and inhibits topoisomerase II. Vosaroxin is not a P-glycoprotein receptor substrate an...

    Authors: Ira K Gordon, Christian Graves, Whoon J Kil, Tamalee Kramp, Philip Tofilon and Kevin Camphausen
    Citation: Radiation Oncology 2012 7:26
  17. To evaluate gold marker displacement due to needle insertion during HDR-brachytherapy for therapy of prostate cancer.

    Authors: Markus KA Herrmann, Tereza Kertesz, Tammo Gsänger, Eugen Bloch, Gerhard Pollul, Mohamed Bouabdallaoui, Arne Strauss, Mareike Herrmann, Hans Christiansen, Hendrik A Wolff, Clemens F Hess and Andrea Hille
    Citation: Radiation Oncology 2012 7:24
  18. Little attention has been paid to the fact that intensity modulated radiation therapy (IMRT) techniques do not easily enable treatment with opposed beams. Three treatment plans (3 D conformal, IMRT, and combin...

    Authors: Viacheslav Soyfer, Yaron Meir, Benjamin W Corn, Dan Schifter, Eliahu Gez, Haim Tempelhoff and Natan Shtraus
    Citation: Radiation Oncology 2012 7:23
  19. The purpose of this study was to evaluate acute and late toxicities of radiotherapy for patients with discoid lupus erythematosus (DLE).

    Authors: Ajaykumar B Patel, Christopher L Hallemeier, Ivy A Petersen, Ashley W Jensen, Thomas G Osborn and Robert C Miller
    Citation: Radiation Oncology 2012 7:22
  20. Non-sinonasal neuroendocrine carcinomas (NSNECs) of the head and neck are considered an unfrequent clinico-pathological entity. Combined modality treatment represents an established therapeutic option for undi...

    Authors: Pierfrancesco Franco, Gianmauro Numico, Fernanda Migliaccio, Paola Catuzzo, Domenico Cante, Paola Ceroni, Piera Sciacero, Pierpaolo Carassai, Paolo Canzi, Maria Rosa La Porta, Giuseppe Girelli, Valeria Casanova Borca, Massimo Pasquino, Santi Tofani, Franca Ozzello and Umberto Ricardi
    Citation: Radiation Oncology 2012 7:21
  21. The purpose of this study was to compare dose distributions from three different algorithms with the x-ray Voxel Monte Carlo (XVMC) calculations, in actual computed tomography (CT) scans for use in stereotacti...

    Authors: Wataru Takahashi, Hideomi Yamashita, Naoya Saotome, Yoshio Iwai, Akira Sakumi, Akihiro Haga and Keiichi Nakagawa
    Citation: Radiation Oncology 2012 7:20
  22. For radiotherapy of the head and neck, 5-point mask immobilization is used to stabilize the shoulders. Still, the daily position of the shoulders during treatment may be different from the position in the trea...

    Authors: Emily Neubauer, Lei Dong, David S Followill, Adam S Garden, Laurence E Court, R Allen White and Stephen F Kry
    Citation: Radiation Oncology 2012 7:19
  23. The timely and appropriate adoption of new radiation therapy (RT) technologies is a challenge both in terms of providing of optimal patient care and managing health care resources. Relatively little is known r...

    Authors: Eman Z AlDuhaiby, Stephen Breen, Jean-Pierre Bissonnette, Michael Sharpe, Linda Mayhew, Scott Tyldesley, Derek R Wilke and David C Hodgson
    Citation: Radiation Oncology 2012 7:18
  24. There are limited data on accelerated partial breast irradiation (APBI) using external beam techniques. Moreover, there are recent reports of increased fibrosis and unacceptable cosmesis with APBI using extern...

    Authors: Arif Y Shaikh, Michael A LaCombe, Hongyan Du, Vathsala T Raghavan, Ranjeev K Nanda and William D Bloomer
    Citation: Radiation Oncology 2012 7:17
  25. To report the initial institute experience in terms of dosimetric and technical aspects in stereotactic body radiation therapy (SBRT) delivered using flattening filter free (FFF) beam in patients with liver le...

    Authors: Pietro Mancosu, Simona Castiglioni, Giacomo Reggiori, Maddalena Catalano, Filippo Alongi, Chiara Pellegrini, Stefano Arcangeli, Angelo Tozzi, Francesca Lobefalo, Antonella Fogliata, Piera Navarria, Luca Cozzi and Marta Scorsetti
    Citation: Radiation Oncology 2012 7:16
  26. Rectal toxicity is less common after 125I seed implant brachytherapy for prostate cancer, and intraoperative rectal dose-volume constraints (the constraint) is still undetermined in pioneering studies. As our con...

    Authors: Ryuji Nakamura, Koyo Kikuchi, Susumu Tanji, Tomonori Yabuuchi, Ikuko Uwano, Satoshi Yamaguchi, Hisanori Ariga and Tomoaki Fujioka
    Citation: Radiation Oncology 2012 7:15
  27. In comparison to the conventional whole-prostate dose escalation, an integrated boost to the macroscopic malignant lesion might potentially improve tumor control rates without increasing toxicity. Quality of l...

    Authors: Michael Pinkawa, Marc D Piroth, Richard Holy, Jens Klotz, Victoria Djukic, Nuria Escobar Corral, Mariana Caffaro, Oliver H Winz, Thomas Krohn, Felix M Mottaghy and Michael J Eble
    Citation: Radiation Oncology 2012 7:14
  28. To identify pretreatment carcinoembryonic antigen (CEA) levels as a risk factor for para-aortic lymph node (PALN) recurrence following concurrent chemoradiotherapy (CCRT) for cervical cancer.

    Authors: Eng-Yen Huang, Yu-Jie Huang, Chan-Chao Chanchien, Hao Lin, Chong-Jong Wang, Li-Min Sun, Chin-Wen Tseng, Ching-Chou Tsai, Yu-Che Ou, Hung-Chun Fu, Hui-Chun Chen, Hsuan-Chih Hsu and Chang-Yu Wang
    Citation: Radiation Oncology 2012 7:13
  29. This is an observational study and the aim is to evaluate the effect of dietary supplements based on Resveratrol, Lycopene, Vitamin C and Anthocyanins (Ixor®) in reducing skin toxicity due to external beam radiot...

    Authors: Rossella Di Franco, MariaGrazia Calvanese, Paola Murino, Roberto Manzo, Cesare Guida, Davide Di Gennaro, Caterina Anania and Vincenzo Ravo
    Citation: Radiation Oncology 2012 7:12
  30. To evaluate the accuracy of the combined maximum and minimum intensity projection-based internal target volume (ITV) delineation in 4-dimensional (4D) CT scans for liver malignancies.

    Authors: Jin Liu, Jia-Zhou Wang, Jian-Dong Zhao, Zhi-Yong Xu and Guo-Liang Jiang
    Citation: Radiation Oncology 2012 7:11
  31. Although proton radiotherapy is a promising new approach for cancer patients, functional interference is a concern for patients with implantable cardioverter defibrillators (ICDs). The purpose of this study wa...

    Authors: Takayuki Hashimoto, Tomonori Isobe, Haruko Hashii, Hiroaki Kumada, Hiroshi Tada, Toshiyuki Okumura, Koji Tsuboi, Takeji Sakae, Kazutaka Aonuma and Hideyuki Sakurai
    Citation: Radiation Oncology 2012 7:10
  32. 131I-MIBG therapy for neuroendocrine tumours may be dose limited. The common range of applied cumulative activities is 10-40 GBq. We report the uneventful cumulative administration of 111 GBq (= 3 Ci) 131I-MIBG i...

    Authors: Samer Ezziddin, Amir Sabet, Yon-Dschun Ko, Sunny Xun, Alexander Matthies and Hans-Jürgen Biersack
    Citation: Radiation Oncology 2012 7:8
  33. Conventional step&shoot intensity modulated radio therapy (IMRT) approaches potentially lead to treatment plans with high numbers of segments and monitor units (MU) and, therefore, could be time consuming at t...

    Authors: Marcello Sabatino, Matthias Kretschmer, Klemens Zink and Florian Würschmidt
    Citation: Radiation Oncology 2012 7:7
  34. Ionizing radiation-induced hematopoietic injury could occur either due to accidental exposure or due to diagnostic and therapeutic interventions. Currently there is no approved drug to mitigate radiation toxic...

    Authors: Shubhankar Suman, Manoj Maniar, Albert J Fornace Jr and Kamal Datta
    Citation: Radiation Oncology 2012 7:6
  35. We hypothesized that quantitative PET parameters may have predictive value beyond that of traditional clinical factors such as the International Prognostic Score (IPS) among Hodgkin's disease (HD) patients.

    Authors: Diane Tseng, Leelanand P Rachakonda, Zheng Su, Ranjana Advani, Sandra Horning, Richard T Hoppe, Andrew Quon, Edward E Graves, Billy W Loo Jr and Phuoc T Tran
    Citation: Radiation Oncology 2012 7:5
  36. Radiation-induced skin injury remains a serious concern for radiation therapy. Heme oxygenase-1 (HO-1), the rate-limiting enzyme in heme catabolism, has been reported to have potential antioxidant and anti-apo...

    Authors: Shuyu Zhang, Chuanjun Song, Jundong Zhou, Ling Xie, Xingjun Meng, Pengfei Liu, Jianping Cao, Xueguang Zhang, Wei-Qun Ding and Jinchang Wu
    Citation: Radiation Oncology 2012 7:4
  37. Treatment of non-small cell lung cancer (NSCLC) is challenging in many ways. One of the problems is disappointing local control rates in larger volume disease. Moreover, the likelihood of both nodal and distan...

    Authors: Carsten Nieder, Adam Pawinski, Astrid Dalhaug and Nicolaus Andratschke
    Citation: Radiation Oncology 2012 7:3
  38. To evaluate the clinical outcomes and patterns of failure in patients with nasopharyngeal carcinoma (NPC) treated with intensity modulated radiotherapy (IMRT) in Northwest China.

    Authors: Jianhua Wang, Mei Shi, Yuesheng Hsia, Shanquan Luo, Lina Zhao, Man Xu, Feng Xiao, Xuehai Fu, Jianping Li, Bin Zhou and Xiaoli Long
    Citation: Radiation Oncology 2012 7:2
  39. For studying proliferation and determination of survival of cancer cells after irradiation, the multiple MTT assay, based on the reduction of a yellow water soluble tetrazolium salt to a purple water insoluble...

    Authors: Karl Buch, Tanja Peters, Thomas Nawroth, Markus Sänger, Heinz Schmidberger and Peter Langguth
    Citation: Radiation Oncology 2012 7:1
  40. Extranodal natural killer/T-cell lymphoma (ENKTL), nasal type, is a rare form of non-Hodgkin lymphoma. Treatment of ENKTL primarily relies on radiation; thus, proper delineation of target volumes is critical. ...

    Authors: Shannon L MacDonald, Liam Mulroy, Derek R Wilke and Steven Burrell
    Citation: Radiation Oncology 2011 6:182
  41. This study examined the population-based use and outcomes of brain radiotherapy (BRT) for brain metastases (BM) from breast cancer with a focus on repeat BRT in the trastuzumab era.

    Authors: Irene Karam, Alan Nichol, Ryan Woods and Scott Tyldesley
    Citation: Radiation Oncology 2011 6:181
  42. This study seeks to increase clinical operational efficiency and accelerator beam consistency by retrospectively investigating the application of statistical process control (SPC) to linear accelerator beam st...

    Authors: Charles M Able, Carnell J Hampton, Alan H Baydush and Michael T Munley
    Citation: Radiation Oncology 2011 6:180
  43. To define the dosimetric coverage of level I/II axillary volumes and the lung volume irradiated in postmastectomy radiotherapy (PMRT) following tissue expander placement.

    Authors: James K Russo, Kent E Armeson, Ryan Rhome, Michele Spanos and Jennifer L Harper
    Citation: Radiation Oncology 2011 6:179
  44. To investigate combining unmodulated electron beams with intensity-modulated radiation therapy to improve dose distributions for superficial head and neck cancers, and to compare mixed beam plans with helical tom...

    Authors: Olivier Blasi, Jonas D Fontenot, Robert S Fields, John P Gibbons and Kenneth R Hogstrom
    Citation: Radiation Oncology 2011 6:178
  45. Targeted drugs have augmented the cancer treatment armamentarium. Based on the molecular specificity, it was initially believed that these drugs had significantly less side effects. However, currently it is ac...

    Authors: Maximilian Niyazi, Cornelius Maihoefer, Mechthild Krause, Claus Rödel, Wilfried Budach and Claus Belka
    Citation: Radiation Oncology 2011 6:177

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.3
    5-year Journal Impact Factor: 3.6
    Source Normalized Impact per Paper (SNIP): 1.197
    SCImago Journal Rank (SJR): 1.033

    Speed 2023
    Submission to first editorial decision (median days): 12
    Submission to acceptance (median days): 132

    Usage 2023
    Downloads: 1,958,690
    Altmetric mentions: 605